First Header Logo Second Header Logo

Connection

Roger Royster to Adrenergic beta-Antagonists

This is a "connection" page, showing publications Roger Royster has written about Adrenergic beta-Antagonists.
Connection Strength

0.325
  1. Zvara DA, Brooker RF, McCall WV, Foreman AS, Hewitt C, Murphy BA, Royster RL. The effect of esmolol on ST-segment depression and arrhythmias after electroconvulsive therapy. Convuls Ther. 1997 Sep; 13(3):165-74.
    View in: PubMed
    Score: 0.151
  2. MacGregor DA, Butterworth JF, Zaloga CP, Prielipp RC, James R, Royster RL. Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced cardiac output following coronary artery bypass grafting. Chest. 1994 Sep; 106(3):835-41.
    View in: PubMed
    Score: 0.122
  3. Harwood TN, Butterworth J, Prielipp RC, Royster RL, Hansen K, Plonk G, Dean R. The safety and effectiveness of esmolol in the perioperative period in patients undergoing abdominal aortic surgery. J Cardiothorac Vasc Anesth. 1999 Oct; 13(5):555-61.
    View in: PubMed
    Score: 0.044
  4. Ririe DG, Butterworth JF, Royster RL, MacGregor DA, Zaloga GP. Triiodothyronine increases contractility independent of beta-adrenergic receptors or stimulation of cyclic-3',5'-adenosine monophosphate. Anesthesiology. 1995 Apr; 82(4):1004-12.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.